TB-500 vs MOTS-c
Compare the research profiles of TB-500 and MOTS-c. Read the individual guides for evidence and limitations.
How to interpret this comparison
This page summarizes database profiles and has not yet received a study-by-study editorial review. These compounds are filed under different research categories, so a direct treatment comparison may not answer a meaningful clinical question. Use the linked guides and primary sources to evaluate a specific claim.
How to read peptide studiesTB-500
Thymosin Beta-4 Fragment
healing
Preclinical (Animal Studies)
not-approved
MOTS-c
MOTS-c (Mitochondrial ORF of the 12S rRNA Type-c)
mitochondrial
Preclinical
not-approved
Detailed Comparison
| Aspect | TB-500 | MOTS-c |
|---|---|---|
| Overview | A synthetic version of a naturally occurring peptide present in virtually all human and animal cells. Studied for cellular regeneration and wound healing properties.... | A mitochondrial-derived peptide described as an "exercise mimetic" that may improve glucose metabolism and physical stamina even without training. Naturally produced during exercise.... |
| Research topics (not established benefits) |
|
|
| Side Effects |
|
|
| Mechanism | Promotes cell migration, blood vessel formation, and regulates actin, a protein that forms cell structure. May reduce inflammation and promote tissue ... | Encoded in mitochondrial DNA, MOTS-c activates AMPK pathway and improves glucose uptake in skeletal muscle. May mimic some metabolic benefits of exerc... |
Frequently Asked Questions
Does a comparison establish which treatment is better?
Only appropriately designed evidence for the same clinical question can support that conclusion. Database categories and mechanisms alone cannot rank treatments.
Does this page establish that these compounds can be combined?
No. This page does not assess interactions or the benefit and safety of combined use. Individual studies cannot establish the effects of a combination.